Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Allograft Nephropathy (CAN)”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT00056784
What this trial is testing

The Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ Transplantation

Who this might be right for
Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 134
Not applicableLooking for participantsNCT01531257
What this trial is testing

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

Who this might be right for
Acute Rejection (AR) of Transplanted KidneyChronic Allograft Nephropathy (CAN)Interstitial Fibrosis (IF)+1 more
Northwestern University 1,000
Not applicableEnded earlyNCT00204230
What this trial is testing

MMF and Calcineurin Inhibitor Withdrawal in CAN

Who this might be right for
Immunosuppressive AgentsKidney Failure, ChronicKidney Transplantation
University Hospital Muenster 86
Post-approval studies (Phase 4)Study completedNCT00634920
What this trial is testing

Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients

Who this might be right for
Renal Function
Novartis Pharmaceuticals 204
Post-approval studies (Phase 4)UnknownNCT00443508
What this trial is testing

Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion

Who this might be right for
Kidney Diseases
Rabin Medical Center 60
Not applicableStudy completedNCT00006328
What this trial is testing

Angiotensin-Converting Enzyme Gene Polymorphism and the Risk of Chronic Allograft Nephropathy

Who this might be right for
Kidney Disease
National Center for Research Resources (NCRR)